Graham Capital Wealth Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Graham Capital Wealth Management's RGEN Position: Q2 2023 in Review
Graham Capital Wealth Management sold out of Repligen (RGEN) in Q2 2023, closing a stake of 200 shares — an estimated $337K sold.
Graham Capital Wealth Management first reported a position in RGEN in Q1 2023 and held it in 1 quarter. The position peaked at $337K in Q1 2023. 447 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.
- Graham Capital Wealth Management reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
- Graham Capital Wealth Management sold 200 Repligen shares in Q2 2023, an estimated $337K.
- Graham Capital Wealth Management first reported a position in Repligen in Q1 2023 and held it in 1 quarter.
- Graham Capital Wealth Management's Repligen position peaked at $337K in Q1 2023.
- 447 funds tracked by Wall St. Rank held Repligen as of Q2 2023.
Based on Graham Capital Wealth Management's 13F filing for Q2 2023, filed 25 Jul 2023.